Credent Connect N Care
Credent Connect N Care Limited is a leading Indian transport and logistics firm specializing in B2B healthcare logistics, cold chain solutions, and warehousing. The company provides critical services including the transportation of diagnostic samples and reagent movement for IVD companies.
Price Band
₹179 - ₹189
Lot Size
1200 Shares
Issue Size
₹93.90 Cr
Fresh Issue
₹93.90 Cr
OFS
N/A
Registrar
AI Sentiment Score
Listing Price
Listed Aug 20
Est. Listing: ₹274 (+45%)
📅 IPO Timeline
✓
Open
Aug 13
✓
Close
Aug 17
✓
Allotment
Aug 18
✓
Refund
Aug 19
✓
Demat
Aug 19
✓
Listing
Aug 20
✨ AI Analysis & Prediction
+35.2%
predicted listing gain
The GMP baseline of 44.97% is adjusted upward due to extraordinary institutional demand (QIB 130.4x), a scarcity-inducing small float size, and exceptional profitability metrics (ROE 40%). The lack of an OFS component further boosts sentiment as 100% of proceeds are used for growth and debt reduction.
💪 Strengths
- Exceptional ROE (40%) and ROCE (61.81%)
- Strong institutional demand with QIB subscription of 130.4x
- 100% Fresh Issue structure ensures capital enters the company
⚠️ Weaknesses
- Lack of listed peers for valuation benchmarking
- Recent sharp spike in profits may raise sustainability questions
🚀 Opportunities
- Expansion of B2B healthcare logistics across more Indian cities
- Increasing demand for cold chain solutions in diagnostic reagent movement
🛡️ Threats
- High dependency on the IVD (In-Vitro Diagnostics) industry
- Potential entry of large-scale logistics players into specialized healthcare niches
🎯 Objectives of the IPO
| Requirement / Purpose | Amount (₹ Cr) |
|---|---|
| Investment in the wholly owned subsidiary, Credent Healthcare Private Limited to meet its working capital requirement | ₹17.89 |
| Investment in the wholly owned subsidiary, Credent Healthcare Private Limited to finance its capital expenditure requirements for machinery | ₹2.05 |
| To meet Working Capital Requirements | ₹26.30 |
| Repayment and/or repayment, in full or part, of borrowing availed by the Company | ₹4.12 |
| General corporate purposes | ₹43.54 |
📊 Financial Overview
| Metric | FY26 |
|---|---|
| Revenue (₹ Cr) | Rs 214.00 Cr |
| Net Profit / PAT (₹ Cr) | Rs 18.00 Cr |
| EBITDA / Op. Profit (₹ Cr) | Rs 29.00 Cr |
| Borrowings (₹ Cr) | Rs 22.00 Cr |
| Total Assets (₹ Cr) | Rs 82.00 Cr |
📋 Live Subscription Status
QIB
130.40x
NII
216.97x
Retail
138.86x
Total
153.13x
Updated: Aug 21, 2026 11:01 AM
💼 Reservation Quota
QIB
50.00%
Retail
46.46%
NII
19.87%
📈 Shareholding & Anchor Lock-In
🔗 Important Links & Lead Managers
- Check Allotment StatusCheck Now →
- Registrar WebsiteVisit →
- Download DRHP ProspectusDownload PDF 📥
- Download RHP ProspectusDownload PDF 📥
Lead Managers / Merchant Bankers
This issue is managed by Hem Securities Ltd., and Share India Capital Services Pvt. Ltd.
Disclaimer: The information provided on this page is for educational and informational purposes only and does not constitute financial advice. IPO investments are subject to market risks. AI-generated analysis is based on publicly available data and may not be accurate. Grey Market Premium (GMP) is unofficial and highly speculative. Always consult a qualified financial advisor and read the DRHP/RHP carefully before making investment decisions.
Founded in 2015, Credent Connect N Care Limited has evolved into a pivotal player in the specialized healthcare logistics sector in India. Over the course of 12 years, the company has built a robust infrastructure designed to handle the sensitive nature of medical transport, ensuring that diagnostic integrity is maintained across its network.
The core business model revolves around B2B Healthcare Logistics Services. This includes the high-precision transportation of diagnostic samples and the movement of reagents from Carrying and Forwarding (C&F) agents to laboratories. By focusing on the In-Vitro Diagnostics (IVD) ecosystem, the company has carved out a high-barrier-to-entry niche.
Operationally, the company boasts a significant scale, serving over 452 cities across India. This vast geographical reach is supported by a massive workforce of over 6,500 healthcare personnel, enabling the firm to offer a comprehensive suite of services including phlebotomist services and home collection options.
The company's growth is driven by an innovative mindset aimed at transforming the healthcare supply chain. By integrating cold chain solutions with warehousing and last-mile delivery, Credent Connect N Care ensures a seamless flow of critical medical supplies.
The leadership team consists of promoters Sandeep Aggarwal, Nikunj Aggarwal, and Esha Gupta, who have steered the company from its inception in 2015 to its current position as a leading logistics provider for the diagnostic industry.
Credent Connect N Care is launching a Book Built Issue to raise approximately ₹93.90 Crores, consisting entirely of a fresh issue with no Offer for Sale (OFS). The IPO is priced with a band of ₹179 to ₹189 per share, with a minimum lot size of 1,200 shares requiring an application amount of ₹2,26,800. The issue is scheduled to open on August 13, 2026, and close on August 17, 2026, with listing on the NSE SME platform on August 20, 2026.
The proceeds from the fresh issue are strategically allocated toward growth and stability. Specifically, ₹17.89 Crores and ₹2.05 Crores are designated for working capital and capital expenditure (machinery) for its wholly owned subsidiary, Credent Healthcare Private Limited. Additionally, ₹26.30 Crores will be utilized for general working capital and ₹4.12 Crores for the repayment of borrowings.
Financial performance has shown an explosive growth trajectory. Revenue surged from ₹78.23 Crores in 2025 to ₹214.43 Crores in 2026. Similarly, the Profit After Tax (PAT) saw a massive jump from ₹2.25 Crores in 2025 to ₹18.45 Crores in 2026, indicating a significant scaling of operations and improved margins.
From a valuation perspective, the company reports a Basic EPS of ₹13.95. While a direct P/E ratio is not provided in the summary, the company's return metrics are stellar, featuring an ROE of 40.0% and a ROCE of 61.81%. There are currently no listed peer companies in India for direct comparison, which often leads to a scarcity premium during listing.
Investment strengths include the 100% fresh issue structure, rapid revenue growth, and high capital efficiency. However, investors should note that the massive jump in 2026 profits needs to be monitored for sustainability. Overall, the issue presents a growth-oriented profile in the specialized healthcare logistics domain.